Fast Facts Egfr Exon 20 Insertion Mutations In Nsclc PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Fast Facts Egfr Exon 20 Insertion Mutations In Nsclc PDF full book. Access full book title Fast Facts Egfr Exon 20 Insertion Mutations In Nsclc.

Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC

Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC
Author: Julia Rotow
Publisher: Karger Medical and Scientific Publishers
Total Pages: 62
Release: 2022-06-30
Genre: Medical
ISBN: 3318070203

Download Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC Book in PDF, ePub and Kindle

Lung cancer is still a major cause of death globally, but the development of personalized, precision medicine has had a marked effect on treatment management and improved clinical outcomes, particularly for those with advanced stage non-small-cell lung cancer (NSCLC). EGFR mutations are the third most common mutation found in patients with advanced stage NSCLC. First-line treatment with a traditional epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) is indicated for most patients, but not for patients with EGFR exon 20 insertion mutations (ex20ins). Instead, recent approvals of an EGFR ex20ins-specific TKI (mobocertinib) and a bispecific antibody (amivantamab) targeting both EGFR and mesenchymalepithelial transition factor (MET) offer the potential for improved outcomes in this patient population. Furthermore, new approaches to treatment continue to be developed and trials for new agents with greater activity against ex20ins mutations are ongoing. Table of Contents: • EGFR and mutations • EGFR mutation testing • Treatment decisions • Therapies in development


Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC

Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC
Author: J. Rotow
Publisher: Karger Medical and Scientific Publishers
Total Pages: 62
Release: 2022-06-13
Genre: Medical
ISBN: 3318071366

Download Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC Book in PDF, ePub and Kindle

Lung cancer is still a major cause of death globally, but the development of personalized, precision medicine has had a marked effect on treatment management and improved clinical outcomes, particularly for those with advanced stage non-small-cell lung cancer (NSCLC). EGFR mutations are the third most common mutation found in patients with advanced stage NSCLC. First-line treatment with a traditional epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) is indicated for most patients, but not for patients with EGFR exon 20 insertion mutations (ex20ins). Instead, recent approvals of an EGFR ex20ins-specific TKI (mobocertinib) and a bispecific antibody (amivantamab) targeting both EGFR and mesenchymalepithelial transition factor (MET) offer the potential for improved outcomes in this patient population. Furthermore, new approaches to treatment continue to be developed and trials for new agents with greater activity against ex20ins mutations are ongoing.


Molecular Pathology of Lung Cancer

Molecular Pathology of Lung Cancer
Author: Philip T. Cagle
Publisher: Springer Science & Business Media
Total Pages: 217
Release: 2012-06-14
Genre: Medical
ISBN: 1461431972

Download Molecular Pathology of Lung Cancer Book in PDF, ePub and Kindle

As with other books in the Molecular Pathology Library Series, Molecular Pathology of Lung Cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular Pathology of Lung Cancer provides the latest information and current insights into the molecular basis for lung cancer, including precursor and preinvasive lesions, molecular diagnosis, molecular targeted therapy, molecular prognosis, molecular radiology and related fields for lung cancer generally and for the specific cell types. As many fundamental concepts about lung cancer have undergone revision in only the past few years, this book will likely be the first to comprehensively cover the new molecular pathology of lung cancer. It provides a foundation in this field for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, thoracic radiologists and their trainees, physician assistants, and nursing staff.


Fast Facts: Non-Small-Cell Lung Cancer

Fast Facts: Non-Small-Cell Lung Cancer
Author: Mary O'Brien
Publisher: Karger Medical and Scientific Publishers
Total Pages: 148
Release: 2022-02-28
Genre: Medical
ISBN: 3318070106

Download Fast Facts: Non-Small-Cell Lung Cancer Book in PDF, ePub and Kindle

Despite an overall decrease in tobacco use, lung cancer (80–85% of which is non-small-cell lung cancer [NSCLC]) is still the leading cause of cancer death in both men and women worldwide. Annual low-dose CT screening of high-risk individuals has the potential to detect early-stage tumors, which can usually be successfully treated with a combination of surgery, radiotherapy and chemotherapy and, in some cases, targeted therapy. However, most patients with NSCLC still present with advanced or metastatic disease. For these patients, initial therapy is guided by the tumor’s molecular characteristics and patient’s performance status. Targeted therapies have significantly improved clinical outcomes and, for some patients with no targetable genetic alterations, immunotherapy has demonstrated significant overall survival benefit. This insightful guide is designed to bring you up to speed with the latest developments and is important reading for all health professionals and medical trainees working in this fast-moving field. Table of Contents: • Prevention and screening • Diagnosis and staging • Surgery • Radiotherapy • Systemic therapy in non-metastatic NSCLC • Systemic therapy in advanced-stage/metastatic disease without a molecular driver • Personalized treatment in advanced NSCLC • Oligometastatic disease and brain metastases


Classification and Regression Trees

Classification and Regression Trees
Author: Leo Breiman
Publisher: Routledge
Total Pages: 370
Release: 2017-10-19
Genre: Mathematics
ISBN: 135146048X

Download Classification and Regression Trees Book in PDF, ePub and Kindle

The methodology used to construct tree structured rules is the focus of this monograph. Unlike many other statistical procedures, which moved from pencil and paper to calculators, this text's use of trees was unthinkable before computers. Both the practical and theoretical sides have been developed in the authors' study of tree methods. Classification and Regression Trees reflects these two sides, covering the use of trees as a data analysis method, and in a more mathematical framework, proving some of their fundamental properties.


Targeted Therapies for Lung Cancer

Targeted Therapies for Lung Cancer
Author: Ravi Salgia
Publisher: Springer
Total Pages: 238
Release: 2019-06-26
Genre: Medical
ISBN: 3030178323

Download Targeted Therapies for Lung Cancer Book in PDF, ePub and Kindle

This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient’s genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.


Fast Facts: Comprehensive Genomic Profiling

Fast Facts: Comprehensive Genomic Profiling
Author: Bernardo L. Rapoport
Publisher: Karger Medical and Scientific Publishers
Total Pages: 109
Release: 2020-10-20
Genre: Medical
ISBN: 3318068187

Download Fast Facts: Comprehensive Genomic Profiling Book in PDF, ePub and Kindle

Cancer is a multifaceted disease in which genetic changes induce uncontrolled tumor growth. Genomic characterization of cancer is now leading to better diagnostic, prognostic and predictive biomarkers, and effective individualized management. 'Fast Facts: Comprehensive Genomic Profiling' provides a crash course in the science, methods and application of genomic profiling. Assuming only the most basic knowledge – or memory – of cell biology, the authors provide an overview of DNA and RNA biology and next-generation sequencing. This sets in context the descriptions of prognostic and predictive biomarkers for different cancer types and genomic-based treatments. Finally, but importantly, some of the practicalities of gaining and interpreting genomic information are described. Whether you need a primer or a refresher, this short colorful book demystifies this complex subject. Contents: • Genetic mutations and biomarkers • Understanding next-generation sequencing • Elements of comprehensive genomic profiles • Role in precision oncology • Predictive and prognostic biomarkers • Overcoming barriers to genotype-directed therapy


IASLC Atlas of ALK and ROS1 Testing in Lung Cancer

IASLC Atlas of ALK and ROS1 Testing in Lung Cancer
Author: Ming Sound Tsao
Publisher:
Total Pages:
Release: 2016-12-04
Genre:
ISBN: 9780983295853

Download IASLC Atlas of ALK and ROS1 Testing in Lung Cancer Book in PDF, ePub and Kindle

The IASLC Atlas of ALK and ROS1 Testing in Lung Cancer is a resource designed to help pathologists, laboratory scientists, and practicing physicians better understand the background, protocol, and interpretation of results of ALK and ROS1 testing for patients with advanced non-small cell lung cancer.


How Tobacco Smoke Causes Disease

How Tobacco Smoke Causes Disease
Author: United States. Public Health Service. Office of the Surgeon General
Publisher:
Total Pages: 728
Release: 2010
Genre: Government publications
ISBN:

Download How Tobacco Smoke Causes Disease Book in PDF, ePub and Kindle

This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.


Histological Typing of Lung and Pleural Tumours

Histological Typing of Lung and Pleural Tumours
Author: W.D. Travis
Publisher: Springer Science & Business Media
Total Pages: 139
Release: 2012-12-06
Genre: Medical
ISBN: 3642600492

Download Histological Typing of Lung and Pleural Tumours Book in PDF, ePub and Kindle

with contributions by Pathologists from 14 Countries